Mater Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cancer, Neurology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers’ and Babies Health. Clinical trials are an essential component of healthcare. They provide the evidence to evaluate the safety and efficacy of new treatments and diagnostics, and provide alternative treatment options for patients with unmet needs.
Mater currently has over 200 active clinical trials. These trials include commercial pharmaceutical and medical device studies, as well as collaborative group studies and investigator-initiated studies, led by Mater’s researchers and collaborators at The University of Queensland and other leading Australian and international medical research institutions.
Without volunteers, clinical trials are not possible. If you are interested in being involved – you may be a patient with a new diagnosis, a patient with a long term diagnosis or a healthy volunteer – view available trials below or contact the Mater Clinical Trials team.
Feasibility of Electrical Impedance Tomography in assessing short-term effects of airway clearance techniques in adults with bronchiectasis, an observational study
Trial Status:
Not yet recruiting
|
Study to compare INBRX-101 to plasma derived A1PI therapy in adults with AATD Emphysema
A clinical trial to evaluate the efficacy, safety and bioavailability of GDC-6599 in patients with chronic cough.
A clinical trial to evaluate the efficacy and safety of MK-5475 for treating pulmonary hypertension associated with chronic obstructive pulmonary disease.
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With Chronic obstructive pulmonary disease (COPD) and Chronic Bronchitis
A Phase 3 clinical study to investigate the use of benralizumab for patients with moderate to very severe chronic obstructive pulmonary disease (COPD)
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with IPF